Tobramycin (CAS 32986-56-4)
See product citations (1)
QUICK LINKS
Tobramycin is an aminoglycoside compound that is widely used in biological research, particularly focusing on its interaction with bacterial ribosomes. Studies involving tobramycin explore its mechanism of binding to the 16S rRNA of the 30S subunit, inhibiting protein synthesis in prokaryotic cells. This action is of interest in molecular biology for probing ribosome structure and function. Additionally, tobramycin is used in microbiology research to study the development of resistance mechanisms in bacteria, which contributes to a broader understanding of antibiotic resistance. Research on the environmental impact of antibiotics also includes tobramycin, examining its presence and degradation in wastewater treatments to assess the potential for antibiotic dissemination into ecosystems.
Tobramycin (CAS 32986-56-4) References
- Elution characteristics of tobramycin from polycaprolactone in a rabbit model. | Hendricks, KJ., et al. 2001. Clin Orthop Relat Res. 418-26. PMID: 11716417
- Pharmacokinetic studies on tobramycin in horses. | Hubenov, H., et al. 2007. J Vet Pharmacol Ther. 30: 353-7. PMID: 17610409
- Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvements. | Chuchalin, A., et al. 2009. Pulm Pharmacol Ther. 22: 526-32. PMID: 19616111
- Pharmacokinetics of intravitreally injected liposome-encapsulated tobramycin in normal rabbits. | Kim, EK. and Kim, HB. 1990. Yonsei Med J. 31: 308-14. PMID: 2077755
- Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin. | Ruddy, J., et al. 2013. J Aerosol Med Pulm Drug Deliv. 26: 69-75. PMID: 22620494
- Pharmacokinetics of tobramycin following intravenous, intramuscular, and intra-articular administration in healthy horses. | Newman, JC., et al. 2013. J Vet Pharmacol Ther. 36: 532-41. PMID: 23531033
- Targeted release of tobramycin from a pH-responsive grafted bilayer challenged with S. aureus. | Lee, HS., et al. 2015. Biomacromolecules. 16: 650-9. PMID: 25585173
- Lung Pharmacokinetics of Tobramycin by Intravenous and Nebulized Dosing in a Mechanically Ventilated Healthy Ovine Model. | Dhanani, JA., et al. 2019. Anesthesiology. 131: 344-355. PMID: 31107274
- Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria. | Idowu, T., et al. 2019. J Med Chem. 62: 9103-9115. PMID: 31557020
- Incorporating Fullerenes in Nanoscale Metal-Organic Matrixes: An Ultrasensitive Platform for Impedimetric Aptasensing of Tobramycin. | Zhang, HW., et al. 2022. ACS Appl Mater Interfaces. 14: 7350-7357. PMID: 35076206
- Thymus vulgaris essential oil + tobramycin within nanostructured archaeolipid carriers: A new approach against Pseudomonas aeruginosa biofilms. | Perez, N., et al. 2022. Phytomedicine. 102: 154179. PMID: 35671606
- Tobramycin Nanoantibiotics and Their Advantages: A Minireview. | Rosalia, M., et al. 2022. Int J Mol Sci. 23: PMID: 36430555
- Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in rats. | Nadai, M., et al. 1993. J Pharm Pharmacol. 45: 971-4. PMID: 7908039
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Tobramycin, 10 mg | sc-204917 | 10 mg | $60.00 | |||
Tobramycin, 50 mg | sc-204917A | 50 mg | $66.00 |